Artificial intelligence in assessing the risks of developing cardiovascular diseases

Main Article Content

Assem Galymova
Hammad Azam


Cardiovascular disease (CVD) is a global health crisis that results in millions of deaths annually. Accurate risk assessment tools are needed to address the increasing incidence of CVD. Medical researchers are leveraging artificial intelligence (AI) to develop innovative solutions for CVD risk assessment. AI - based predictive models offer personalized and precise risk assessments, overcoming the limitations of traditional regression models. These predictive models help medical professionals cater to individual patients ' unique needs , identify those at higher risk , and provide targeted interventions and personalized treatment plans , improving ultimately patient outcomes and healthcare efficiency. AI can also be integrated into decision support and medical information systems to automatically identify risk factors and assess CVD risks, including data extraction from medical records. This knowledge helps healthcare professionals make informed decisions and provide better care for patients with or at risk for CVD. The integration of AI in CVD risk assessment can potentially revolutionize cardiovascular medicine, paving the way for early interventions and personalized treatment plans.

Google Scholar

Article Details

How to Cite
Galymova, A., & Azam, H. (2023). Artificial intelligence in assessing the risks of developing cardiovascular diseases. Scientific Collection «InterConf», (146), 260–265. Retrieved from


Benjamin, E. J., Muntner, P., Alonso, A., Bittencourt, M. S., Callaway, C. W., Carson, A. P., ... & Khan, S. S. (2019). Heart disease and stroke statistics—2019 update: a report from the American Heart Association. Circulation, 139(10), e56-e528.

Chiarito, M., Luceri, L., Oliva, A., Stefanini, G. G., & Condorelli, G. (2022). Artificial Intelligence and Cardiovascular Risk Prediction: All That Glitters is not Gold. European Cardiology Review, 17, e29.

Barabási, A. L., Gulbahce, N., & Loscalzo, J. (2011). Network medicine: A network-based approach to human disease. Nature Reviews Genetics, 12, 56–68.

Liu, Y., Chen, P. C., Krause, J., & Peng, L. (2019). How to Read Articles That Use Machine Learning: Users’ Guides to the Medical Literature. JAMA, 322(18), 1806–1816. jama.2019.16489

Weng, S. F., Reps, J., Kai, J., Garibaldi, J. M., & Qureshi, N. (2017). Can machine-learning improve cardiovascular risk prediction using routine clinical data? PLOS ONE, 12(4), e0174944.

Karatzia, L., Aung, N., & Aksentijevic, D. (2022). Artificial intelligence in cardiology: Hope for the future and power for the present. Frontiers in Cardiovascular Medicine, 9, 945726.

Knuuti, J., Wijns, W., Saraste, A., Capodanno, D., Barbato, E., Funck-Brentano, C., Prescott, E., Storey, R. F., Deaton, C., Cuisset, T., Agewall, S., Dickstein, K., Edvardsen, T., Escaned, J., Gersh, B. J., Svitil, P., Gilard, M., Hasdai, D., Hatala, R., … Bax, J. J. (2020). 2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes. European Heart Journal, 41(3), 407–477.

Dey, D., Slomka, P., Leeson, P., Comaniciu, D., Shrestha, S., Sengupta, P.P., Marwick, T.H., Neglia, D., Senior, R., Yang, G.-Z. and Jabbour, A., 2019. Artificial Intelligence in Cardiovascular Imaging. Journal of the American College of Cardiology, 73(11), pp.1317-1335.